Exabis Library
Welcome to the e-CCO Library!
P297: The change of bone mineral density in patients with inflammatory bowel disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P297: The Toronto IBD Global Endoscopic Reporting (TIGER) Score and its Ability to Predict Outcomes Regarding Steroid and Biologic Use in Ulcerative Colitis and Crohn's Disease Patients – A Construct Validation Study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P297: Treatment of patients with complex perianal Crohn's disease with darvadstrocel: a single-institution real life experience.
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P297: Ulcerative colitis and proximal extension of the disease: a sub-group with worse prognosis?
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P298 Patient-reported outcomes: the ICHOM standard set for IBD in real-life practice helps quantify deficits in current care
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P298: Budesonide MMX versus Prednisolone for Ulcerative Colitis: Comparative outcomes from a British retrospective multi-centre study
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P298: Comparison between clinical and patient-reported symptoms among Crohn's disease and ulcerative colitis patients
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P298: Comparison of the familial and sporadic cases of inflammatory bowel diseases in long-term follow-up regarding step-up treatment, clinical, and biochemical parameters
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P298: Crohn’s disease or intestinal tuberculosis: The unsolved enigma
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P298: Pregnancy in Crohn's and Colitis - Observations, Levels and Outcomes Extension (PICCOLO-X) Study: Biological therapy reduces faecal calprotectin and the need for corticosteroids in pregnant women with Inflammatory Bowel Disease
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P298: Risk factors for the progression of non-alcoholic fatty liver disease in people with inflammatory bowel disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P298: Wall thickness ratio, a new magnetic resonance parameter, predicts the outcome of biological therapy in patients with ileal and ileocolonic Crohn’s disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P299 A prospective randomised trial comparing dye-based chromoendoscopy with electronic virtual chromoendoscopy for detection of colonic neoplastic lesions during IBD surveillance colonoscopy
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P299: A novel ileocolonic Crohn’s staging tool: the development and validation of an evidence-based, end-user informed radiological decision-aid
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P299: Disability in newly diagnosed patients with Crohn´s Disease: initial results from the prospective CROCO (Crohn´s Disease Cohort) Study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P299: Identification of a prognostic biomarker able to predict ulcerative colitis patients that will not respond to standard therapy
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P299: Is quality of life different between Crohn’s disease patients submitted to early surgery or immunosuppression?
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P299: Loss-of-response to anti-tumour necrosis factor-α critically depends on treatment duration in patients with Inflammatory Bowel Disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P299: Prediction model for steroid-free clinical remission with vedolizumab at week 22 in patients with Ulcerative Colitis: Machine learning using clinical data at baseline
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P299: Relation of body mass index and health outcomes in elderly patients with inflammatory bowel disease (IBD)
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM